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Detection of small-molecule enzyme inhibitors with peptides
isolated from phage-displayed combinatorial peptide libraries
R Hyde-DeRuyscher1*, LA Paige1*, DJ Christensen1, N Hyde-DeRuyscher1,
A Lim2, ZL Fredericks1, J Kranz2, P Gallant2, J Zhang2, SM Rocklage2,
DM Fowlkes1, PA Wendler2 and PT Hamilton1
Background: The rapidly expanding list of pharmacologically important targets
has highlighted the need for ways to discover new inhibitors that are
independent of functional assays. We have utilized peptides to detect inhibitors
of protein function. We hypothesized that most peptide ligands identified by
phage display would bind to regions of biological interaction in target proteins
and that these peptides could be used as sensitive probes for detecting low
molecular weight inhibitors that bind to these sites.
Results: We selected a broad range of enzymes as targets for phage display
and isolated a series of peptides that bound specifically to each target. Peptide
ligands for each target contained similar amino acid sequences and competition
analysis indicated that they bound one or two sites per target. Of 17 peptides
tested, 13 were found to be specific inhibitors of enzyme function. Finally, we
used two peptides specific for Haemophilus influenzae tyrosyl-tRNA synthetase
to show that a simple binding assay can be used to detect small-molecule
inhibitors with potencies in the micromolar to nanomolar range.
Conclusions: Peptidic surrogate ligands identified using phage display are
preferentially targeted to a limited number of sites that inhibit enzyme function.
These peptides can be utilized in a binding assay as a rapid and sensitive
method to detect small-molecule inhibitors of target protein function. The
binding assay can be used with a variety of detection systems and is readily
adaptable to automation, making this platform ideal for high-throughput
screening of compound libraries for drug discovery. 
Introduction
In recent years, the rate of accumulation of genomic
sequence information has rapidly accelerated. The DNA
sequences of yeast, nematode and 22 microbial genomes
have been completely determined and the sequencing of
the human, mouse and 71 additional microbial genomes is
underway (http://www.ncbi.nlm.nih.gov/PMGifs/Genomes/
bact.html). This information has aided in the identification
of genes whose products could serve as targets for pharma-
cological intervention. Although the accumulation of
sequence information has been rapid, functional informa-
tion for the corresponding gene products has lagged behind.
For example, 40% of the open reading frames in Escherichia
coli encode proteins of unknown function, even though this
microbe has been scrutinized for decades [1]. This lack of
functional information makes it difficult to develop assays
to exploit these genes as potential drug targets. Even when
detailed knowledge of the target protein is available, it is
often difficult to develop an assay amendable for use in a
high-throughput screen of compound and natural-product
libraries. Techniques and tools that facilitate the screening
process independent of functional assays are therefore
needed to efficiently exploit available targets. One
approach to this problem is to develop probes that are spe-
cific for functional sites of target proteins and use them in a
binding assay to detect inhibitors. Functional sites are
regions on the target protein where the binding of another
molecule can modulate the activity of the target. Functional
sites of enzymes can be the site of enzyme–substrate inter-
action (the active site) or allosteric regulatory sites. Combi-
natorial peptide libraries have been used as a source of
surrogate ligands that bind to various macromolecules.
Libraries have been synthesized on beads [2], pins/crowns,
polysomes, in solution [3–5] and displayed on the surface of
phage [6–8] or E. coli [9,10]. Each of these approaches has
been successful in identifying peptides that bind to many
different types of proteins including antibodies [8],
enzymes [11], oncoproteins [12,13] and receptors [14]. The
most exploited method, phage display, presents random
peptides on the surface of bacteriophage M13 (reviewed in
[15,16]). The large size of the libraries (> 1 × 109 members),
the renewable nature of the library and the relative ease
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with which the libraries are screened make it a powerful
technique for identifying peptide ligands. Iterative rounds
of binding, washing, elution and amplification give rise to
populations of phage with an increasing proportion display-
ing peptides that bind to the target protein. The sequences
of peptides isolated using phage display can often be
aligned to identify consensus-binding motifs, and peptides
with similar sequences often bind to a common site on the
surface of the target protein.
We hypothesized that phage display could be used to iso-
lated peptides that bind to regions of biological interaction
on target proteins, specifically sites of enzyme–substrate
interaction, and that these peptides can be used to detect
compounds that bind at these sites. A series of well-charac-
terized enzymes with diverse structures, functions and
established biochemical assays were selected as targets for
the isolation of peptide ligands by phage display. Peptides
affinity-selected for each target were grouped on the basis
of primary sequence homology. A synthetic peptide repre-
sentative of each sequence cluster was then tested for its
capacity to inhibit enzyme function and the kinetic mecha-
nism of inhibition was assessed. Finally, we examined the
utility of peptide ligands as screening tools by investigating
the ability of two peptides to detect known inhibitors of
the Haemophilus influenzae tyrosyl-tRNA synthetase.
Results
The goal of this study was to test whether peptides iso-
lated by phage display would bind preferentially to func-
tional sites on enzymes allowing the peptides to modulate
enzyme function and if these peptides could then be used
as probes to detect enzyme inhibitors. A variety of
enzymes from a wide range of classes were selected for
study (Table 1). Phage were selected for binding from 12
libraries displaying a total of ~1.5 × 1010 peptides. Results
for each enzyme are described below.
Identification of peptide ligands and inhibition studies
TyrRS
Tyrosyl-tRNA synthetase (TyrRS) from H. influenzae cat-
alyzes the charging of the amino acid tyrosine to tRNATyr
(Table 1). Phage were affinity selected on TyrRS immo-
bilized by method 1 (see the Materials and methods
section) and the selected peptide sequences are pre-
sented in Table 2. The sequences fell into two distinct
but related sequence homology clusters, plus two addi-
tional unrelated peptides. Two peptides from each cluster
as well as the two unrelated peptides were synthesized for
further analysis (Table 2).
To determine whether the peptides were binding to the
same site, we attempted to block the binding of individual
phage with synthetic peptides or with an inhibitor that
mimics the aminoacyladenylate intermediate. Synthetic
peptides Tyr-1 and Tyr-2 (cluster 1) effectively competed
for binding with phages 1 and 14 (the respective parent
phage), but did not affect the binding of phages 22, 24, 25
and 26. Synthetic peptides Tyr-3 and Tyr-4 (cluster 2)
were effective competitors with phages 1, 14, 22 and 24.
Synthetic peptides Tyr-5 and Tyr-6 did not compete for
binding with any of the tested phage. Preincubation of the
enzyme with a small-molecule inhibitor effectively
blocked the binding of phage from the first cluster, but
had no effect on the binding of the remaining phage (data
not shown). It is not clear why peptides from the second
cluster block the binding of phage from clusters 1 and 2,
whereas peptides from the first cluster block binding of
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Table 1
Enzymes targeted by phage display.
Target Enzyme class Reaction(s) catalyzed
Tyrosyl tRNA synthetase
(Haemophilus influenzae) Ligase Tyrosine + ATP → Tyrosyladenylate + PPi
Tyrosyladenylate + tRNA → Tyr-tRNA + AMP
Proline RS (E. coli ) Ligase Proline + ATP → Prolyladenylate + PPi
Prolyladenylate + tRNA → Pro-tRNA + AMP
Alcohol dehydrogenase Oxidoreductase Ethanol + NAD+ → Acetaldehyde + NADH + H+
(Saccharomyces cerevisiae)
Carboxypeptidase B Hydrolase (Amino acid chain)n → (Amino acid chain)n–1
(Sus scrofa – pig)
β-glucosidase Hydrolase (Glucose)n → (Glucose)n–1 + Glucose
(Agrobacterium faecaelis)
Hexokinase (S. cerevisiae) Transferase Glucose + ATP → ADP + Glucose 6-phosphate
Glycogen phosphorylase a Transferase (Glucose)n + PI → (Glucose)n–1 + Glucose 1-phosphate
(Oryctolagus cuniculus – rabbit)
List of targets used in this study, the enzyme class to which each belongs and a summary of the reaction catalyzed by each. 
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phage only from the first cluster. It might be that the pep-
tides from the first cluster bind in a deep pocket on the
enzyme, whereas those in the second cluster bind near the
top of this pocket and prevent the access. Collectively,
these results imply that peptides Tyr-1–Tyr-4 bind to
overlapping sites whereas peptides Tyr-5 and Tyr-6
appear to bind to distinct sites on TyrRS.
Each of the synthetic peptides was tested for its ability to
act as an inhibitor of enzyme activity. Peptides Tyr-1–
Tyr-4 were found to inhibit enzyme function with Ki
values in the nanomolar range (Figure 1 and Table 3).
The two unrelated peptides, Tyr-5 and Tyr-6, did not
inhibit enzymatic activity. Within a cluster, the relative Ki
values obtained for the peptides corresponded to the
affinities observed in the phage-titration experiments.
ProRS
Prolyl-tRNA synthetase (ProRS) from E. coli catalyzes the
charging of the amino acid proline to tRNAPro (Table 1).
Peptides, affinity selected for ProRS immobilized using
methods 3 or 4 were grouped into three distinct sequence-
homology clusters (Table 2). Phage titrations indicated
that several peptides had relatively high affinity for
ProRS. Competition assays between phage and an
inhibitor of ProRS resulted in a tenfold reduction in the
phage ELISA signal, indicating that phage binding was
sensitive to the presence of an inhibitor (data not shown).
One of the tightest binding peptides, Pro-3, was synthe-
sized and kinetic analysis revealed that this peptide inhib-
ited ProRS activity with a nanomolar Ki value (Table 3).
Alcohol dehydrogenase
Alcohol dehydrogenase (ADH) from Saccharomyces cere-
visiae catalyzes the conversion of ethanol to acetaldehyde
using NAD+ as a cofactor (Table 1). Affinity selection of
peptides was carried out on ADH immobilized using
methods 2–4. Two distinct sequence-homology clusters
and several outlying sequences that bound specifically to
ADH were identified (Table 3). Phage titrations were con-
ducted to rank the relative affinity of the displayed pep-
tides and two of the tightest binding peptides were chosen
for further analysis. Kinetic analysis revealed that both
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Table 2
Peptide sequences encoded by phage that bound specifically to
(a) TyrRS, (b) prolyl-tRNA synthetase (ProRS), (c) alcohol
dehydrogenase, (d) β-glucosidase, (e) hexokinase, (f) glycogen
phosphorylase a and (g) carboxypeptidase B were aligned by
maximizing the number of conserved residues in the same primary
sequence. The sequences shown are the peptides displayed on the
surface of the mature phage. For the peptides that begin with ‘SR’ or
‘SS’, the first two residues are encoded by cloning sites and these
residues are therefore fixed. Peptides that contain two cysteine residues
(underlined) may form disulfide bridges between the cysteines to display
a constrained peptide. The ELISA signal corresponding to absorbance
at 405 nm for 109 pfu/ml were used to determine the relative affinities to
the target for each phage clone as described in the Materials and
methods section (phage affinity titrations). ND, not determined. 
cm7108.qxd  02/08/2000  01:36  Page 19
synthetic peptides inhibited ADH activity at nanomolar
concentrations (Table 3). The relative Ki values obtained
for the peptides correspond to the affinities observed in
the phage titration experiments.
β-Glucosidase
β-Glucosidase from Agrobacterium faecalis catalyzes the
hydrolysis of β-glucosides (Table 1). Affinity selection of
phage was conducted on β-glucosidase immobilized using
methods 3 or 4 and two distinct sequence clusters of pep-
tides were identified (Table 2). Immobilized β-glucosi-
dase was pre-incubated with 3 mM conduritol, a covalent
inactivator of the protein that acts via acylation of an
active-site glutamate residue, to prevent binding at the
active site. Phage displaying peptides from the second
cluster (sequences 4–10) were prevented from binding. In
contrast, binding of phage from the first cluster
(sequences 1–3) was not affected. Phage titrations were
conducted to rank the phage in terms of affinity (Table 2)
and three of the highest affinity peptides were synthe-
sized for kinetic evaluation. Peptides Glu-4 and Glu-8
inhibited β-glucosidase activity with Ki values of 400 nM
and 4 µM, respectively, but Glu-3 did not inhibit enzyme
activity (Table 3). For the peptides that inhibited β-glu-
cosidase activity, the relative Ki values correspond to the
affinities observed in the phage titration experiments. It is
interesting to note that peptides derived from phage that
were sensitive to conduritol inactivation also inhibit
enzyme activity.
Hexokinase
Hexokinase (HK) from S. cerevisiae catalyzes the phospho-
rylation of D-glucose by ATP to yield D-glucose 6-phos-
phate (Table 1). Peptides affinity selected for HK were
isolated using method 4. Seven peptide sequences were
identified, six of which showed similarity and could be
grouped into a sequence homology cluster (Table 2).
Phage titrations were conducted to rank the affinity of the
phage (Table 2) and two of the highest affinity peptides,
Hex-3 and Hex-7, were synthesized for more detailed
analysis. Both peptides blocked the binding to HK of the
all phage tested, whereas addition of an unrelated peptide
had no effect (data not shown). Therefore, even though
the peptides are unrelated by primary sequence, it is
likely that they bind to overlapping sites.
Kinetic analysis indicated that peptides Hex-3 and Hex-7
inhibited HK with Ki values ranging from low micromolar
to low nanomolar, respectively (Table 3). The relative Ki
values obtained for the peptides correspond to the affini-
ties observed in the phage titration experiments.
Glycogen phosphorylase a
Glycogen phosphorylase a (Pa) from rabbit muscle cat-
alyzes the removal and phosphorylation of the terminal
glucose residue of glycogen to generate glucose-1-phos-
phate (Table 1). Peptides affinity-selected for Pa were iso-
lated using method 4 and seven peptides that fell into three
sequence homology clusters were identified (Table 2). The
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Figure 1
Inhibition of tyrosyl-tRNA synthetase activity by
peptides Tyr-1 and Tyr-4. Enzyme inhibition of
TyrRS was monitored using a charging assay
as described in the Materials and methods
section. (a) Secondary plots of the apparent Ki
versus substrate concentration with peptide
Tyr-1 indicating competitive inhibition with
respect to tyrosine and mixed inhibition with
respect to ATP. (b) Secondary plots of the
apparent Ki versus substrate concentration for
the peptide Tyr4 indicating noncompetitive
inhibition with respect to both tyrosine and
ATP. Similar experiments were conducted for
each peptide–enzyme pair to determine the
mechanism of inhibition in Table 3.
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relative affinity of each peptide for Pa was evaluated using
phage titrations (Table 2) and two of the highest affinity
were chosen for synthesis and kinetic evaluation. Enzyme
inhibition studies with synthetic peptides, Pa-2 and Pa-7,
showed that both were effective in inhibiting the enzyme
activity with Ki values in the 10–25 µM range.
Carboxypeptidase B
Carboxypeptidase B (CPB) is a metalloprotease that
cleaves proteins adjacent to arginine and lysine residues
(Table 1). Phage affinity selection on CPB immobilized
by method 4 identified three peptides, two of which
shared extensive sequence homology. The phage had low
affinity for CPB as determined by affinity titrations
(Table 2). The highest affinity peptide, CP-1, was synthe-
sized for kinetic analysis, which indicated that the peptide
was not an inhibitor of enzyme activity (Table 3). 
Detection of TyrRS inhibitors using synthetic peptides
The second goal of this study was to evaluate the use of
these peptides as probes to detect inhibitors. We chose two
peptides specific for TyrRS (Tyr-1 and Tyr-4) that had dif-
ferent inhibition mechanisms, as determined by kinetic
evaluation, and tested their ability to detect known TyrRS
inhibitors. Inhibitors A and B in the test set had been
shown previously to be competitive inhibitors with respect
to both tyrosine and ATP (data not shown). We used three
different detection systems, scintillation proximity, time-
resolved fluorescence and fluorescence polarization, to
determine whether the binding of these peptides was sen-
sitive to the presence of an inhibitor. The scintillation prox-
imity and time-resolved fluorescence methods use
immobilized target protein, whereas the fluorescence polar-
ization assay is a homogenous assay with the target, peptide
and compound in solution (see the Materials and methods
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Table 3
Enzyme inhibition using synthetic peptides.
Titration curves Secondary plots Proposed
Enzyme Peptide Substrate (rate versus [peptide]) (Ki app versus [S]) Ki (nM) mechanism
TyrRS Tyr-1 Tyrosine Simple Linear; slope = y-int/Km 80 C
ATP Simple Hyperbolic; limit = 0.65 µM 60 M
Tyr-2 Tyrosine Sigmoidal Unclear ND ND
ATP Sigmoidal Hyperbolic; limit = 4 µM 500 ND
Tyr-3 Tyrosine Simple Linear; slope = 0 500 NC
ATP Simple Linear; slope = 0 800 NC
Tyr-4 Tyrosine Sigmoidal Linear; slope = 0 300 NC
ATP Sigmoidal Linear; slope = 0 500 NC
Tyr-5 Tyrosine – – dni –
ATP – – dni –
Tyr-6 Tyrosine – – dni –
ATP – – dni –
ProRS Pro-3 Proline Sigmoidal Hyperbolic; limit = 3 µM 500 M
ATP Sigmoidal Hyperbolic; limit = 1.2 µM 400 M
β-Glucosidase Glu-3 PNPG – – dni –
Glu-4 PNPG Sigmoidal Linear; slope = 0 400 NC
Glu-8 PNPG Simple Linear; slope = 0 4000 NC
Hexokinase Hex-3 Glucose Simple Parabolic; limit = 16 µM 900 C
ATP Simple Hyperbolic 4000 M
Hex-7 Glucose Sigmoidal Parabolic 80 C
ATP Sigmoidal Linear; slope = 0 100 NC
Glycogen Pa-2 Glycogen ND ND 30,000 ND
phosphorylase a Pa-7 Glycogen ND ND 10,000 ND
Alcohol ADH-1A Ethanol Simple Hyperbolic; limit = 1.4 µM 100 M
dehydrogenase NAD Simple Linear; slope = y-int/Km 800 C
ADH-4C Ethanol Sigmoidal Linear; slope = y-int/Km 300 C
NAD Simple Linear; slope > y-int/Km 500 ND
Carboxypeptidase B CP1 Hipp-Arg – – dni –
Summary of enzyme inhibition studies using synthetic peptides.
Experiments for secondary plots was conducted with saturating
concentrations of fixed substrate. For hexokinase, the observation of
parabolic KI,app versus [S] for glucose excludes any simple
mechanism. For alcohol dehydrogenase, the sigmoidal inhibition
determined for ethanol and anomalous linear, secondary plot for NAD
excludes any simple mechanism. C, competitive; NC, noncompetitive;
M, mixed; dni, did not inhibit; ND, not determined.
cm7108.qxd  02/08/2000  01:36  Page 21
section). The concentration of inhibitor that reduced
peptide binding to 50% of the maximal signal (EC50) was
then compared with the IC50 values for the same inhibitors
determined by the standard biochemical charging assay for
TyrRS activity, which monitors the transfer of [3H]-tyro-
sine to tRNATyr (Figure 2 and Table 4). Each assay format
detected all of the inhibitors tested, even those with poten-
cies in the micromolar range. The absolute EC50 value in
the binding assay was dependent on the concentration of
target protein present (data not shown) and under the con-
ditions used here, in most cases, the binding assay yielded
potencies comparable to those found with the functional
assay. This correlation was unexpected in that the binding
assay is carried out in the absence of substrates, whereas
the functional assay contains all substrates. Both peptides
were sensitive probes for the detection of these inhibitors,
even though peptide Tyr-4 was a noncompetitive inhibitor
(Table 3). This assay was used to screen a 640-member
library (LOPAC, RBI; see the Materials and methods
section) for compounds that would disrupt the interaction
between Tyr-1 and TyrRS. With the exception of known
inhibitors added as controls, none of the 640 compounds
were found to be inhibitors, indicating that the detection of
inhibitors using this assay is not disrupted by a vast major-
ity of small molecules and does not, therefore, suffer from a
high rate of nonspecific disruption. These results indicate
that peptides identified using phage display can be used in
competitive binding assays to detect inhibitors of enzyme
function, and the mechanism by which the peptides bind
to the target do not a priori exclude their use as an effective
tool to detect inhibitors.
Discussion
To utilize effectively the rapidly expanding list of useful
targets in the drug-discovery process, new techniques and
tools are needed that accelerate the identification of
inhibitors without relying on functional assays. The start-
ing point for this study was the premise that peptides that
bound to proteins would bind preferentially to functional
sites and that these peptides could be used to identify
inhibitors of the target proteins function. We chose a
variety of biochemically well-characterized enzymes from
a broad range of classes and used phage display to isolate
peptides that bound to each enzyme.
A majority of the peptides tested inhibited the function of
the enzyme for which they were affinity selected. The
peptides that bound to these targets showed a clustering
of similar residues within the sequences, suggesting that
the peptides adopt a similar structure when binding to the
enzyme and probably, therefore, bind to the same sites.
Data from competition experiments between synthetic
peptides and phage displaying related sequences were
consistent with this hypothesis. Surprisingly, in several
instances where multiple sequence homology clusters to
the same target were identified, peptides with unrelated
sequences effectively competed with some of the
peptide-displaying phage. This implies that the peptides
are binding to overlapping sites and provides strong evi-
dence for the preferential selection of peptides that bind
to a limited number of sites on the target. When these
peptides were tested for their ability to inhibit biochemi-
cal activities of the various enzymes, 13 of 17 were found
to be effective inhibitors. If we confine the analysis to
peptides derived from sequence clusters and exclude out-
liers, 12 of 14 peptides were found to inhibit the activity of
6 out of 7 enzymes.
Kinetic analysis of the peptides did not reveal a general
trend in the mechanism of inhibition by the inhibitory
peptides. Titration curves of rate versus inhibitor concen-
tration at a fixed substrate concentration were often non-
first order, suggesting that target inhibition was not
simple mechanistically. The peptides for hexokinase and
alcohol dehydrogenase displayed competitive kinetics
with respect to at least one of the substrates, suggesting
that they are binding to the substrate-binding sites of
these enzymes. Further evidence that the peptides are
targeting functional sites came from using the phage
themselves as reagents. In the case of ProRS, peptide
Pro-3 showed complex inhibition kinetics (non-first-order
dose-response curves, mixed inhibition), but the binding
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Figure 2
Dose-response curves in the binding assay using the Tyr-1 peptide
and inhibitors. The peptide binding assay using time-resolved
fluorescence for detection was carried out as described in the
Materials and methods section. Compounds A–D are described in
Table 4. To show the specificity of inhibition in the peptide binding
assay, Compound Z, a specific inhibitor for ProRS that does not inhibit
TyrRS in a charging assay, was included as a negative control.
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of the parent phage to the target could be prevented by
addition of a competitive inhibitor of the enzyme. Simi-
larly, phage binding to β-glucosidase could be prevented
by incubation of the immobilized enzyme with conduritol
epoxide, even though peptides Glu-4 and Glu-8 were
both noncompetitive inhibitors of the enzyme. The
binding of phage displaying peptide Tyr-2 to TyrRS
could be blocked by a competitive inhibitor even though
the inhibition mechanism of this peptide was unclear.
The ability to identify peptides that inhibit the activity of
such a variety of targets indicates that this method of
identifying surrogate ligands is a powerful tool that can be
applied across a diverse range of enzyme classes.
These observations provide strong evidence that the pep-
tides interact with functional sites on the enzymes and
not randomly with the protein surface. Although the
mechanism by which this selective targeting occurs is
unclear, an explanation could lie in physical properties of
functional sites. They are generally pockets in the protein
surface with a higher composition of arginine, histidine,
tryptophan and tyrosine residues than other surface
exposed regions of proteins [17]. The functional sites of
even vastly different proteins share, therefore, some
common characteristics. Crystallographic and thermody-
namic data have been used to suggest that a large part of
the binding energy for enzyme–substrate interactions is
derived from the displacement of water molecules from
these cavities [18–20], and it is possible that these same
forces drive the binding of peptide ligands identified
using phage display. One piece of information consistent
with this idea is the high content of residues with bulky
hydrophobic groups, especially tryptophan, in all of the
peptides described in this work. In spite of their similar
compositions, the peptides are exquisitely specific for
their cognate target protein (i.e. none of the peptides
cross-reacts with other target proteins). This could indi-
cate a common driving force in the binding of these pep-
tides, whereas the specificity for each target could come
from the spacing of these residues as well as other amino
acids in the sequence.
An important aspect of the approach described here is that
a functional assay is not required to identify these sites. We
tested the activity of each of the targets in this study to
show that they were in an active conformation prior to the
start of each selection. This was done because we found
that affinity selections carried out on targets that were inac-
tivated (either by binding to plastic or over biotinylation)
did not yield any specific binding phage. Presenting the
target protein in different ways (see the Materials and
methods section) often identified the same phage that
bound a given target and was not a critical factor in the suc-
cessful identification of specific binding phage. The critical
aspect of this approach, therefore, is to present the target in
an active conformation. If gentle immobilization conditions
are used, such as limited biotinylation, knowledge of the
activity of the target protein is not required to identify
peptide ligands that bind specifically. This raises the possi-
bility of using this technique to identify functional sites on
proteins of unknown function. Work to assess the utility of
this approach on less characterized proteins is in progress.
One important implication of these phenomena is that
peptides derived from phage display can be valuable tools
aiding the identification of small-molecule inhibitors.
Using synthetic peptides that bound to TyrRS, we
showed that a simple competitive binding assay could be
used to detect inhibitors with a wide range of potencies.
This was true for peptides that were either competitive or
noncompetitive inhibitors of TyrRS, indicating that, at
least in this case, the inhibition mechanism for the
peptide does not exclude its use as an effective screening
tool. We formatted the assay using three different detec-
tion methods (scintillation proximity, time-resolved fluo-
rescence and fluorescence polarization), showing the
versatility of this approach. Peptide ligands isolated by
phage display can, therefore, be used sensitive probes for
the detection of inhibitors.
Significance
Formatting an assay suitable for high-throughput
screening is a difficult task, even when there is detailed 
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Table 4
Detection of inhibitors with biochemical and peptide binding assays.
Time-resolved Fluorescence
Compound Charging Flash plate fluorescence polarization
Inhibitor MW cLogP class assay assay assay assay
IC50 (mM) EC50 (mM) EC50 (mM) EC50 (mM)
Tyr-1 Tyr-4 Tyr-1 Tyr-1
A 508.51 –1.63 Aminoacyl intermediate mimic 0.04 0.03 1 0.008 0.02
B 516.76 4.53 Aromatic pyrazole acid 0.20 0.2 0.08 0.1 0.2
C 391.25 3.16 Pyrazole amide 0.6 8.0 2.0 ≅10.0 ND
D 494.35 5.01 N-Sulfonyl acyl hydrazide 3.0 7.0 2.0 6.0 2
Comparison of biochemical charging assay and peptide binding assay. ND, not determined.
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knowledge of the protein being studied. This task
becomes even more difficult when the protein is not well
characterized. We have shown that peptides isolated
using phage display can be used to format assays for
enzyme targets. We have found that many (13 of 17) pep-
tides identified using phage display target functional sites
on enzymes, the same sites to which effective therapeu-
tics must be targeted. We have also shown that these pep-
tides can be used in a simple competitive binding assay to
identify small-molecule inhibitors of enzyme function.
The assay is easy to format, flexible enough to be used
with a number of detection systems and readily adaptable
to automation. These characteristics make it ideal for
high-throughput screening of large libraries of com-
pounds. This assay can be used in the same format for
enzymes with a wide variety of activities. This simplifies
and accelerates the process of screen development and




Immulon 4 plates (96 well), were purchased from Dynatech. Strepta-
vidin, bovine serum albumin, conduritol epoxide, yeast alcohol dehydro-
genase and rabbit muscle glycogen phosphorylase a were purchased
from Sigma. Streptavidin-coated paramagnetic particles were from
Promega. Anti-M13 antibody coupled to horseradish peroxidase was
obtained from Pharmacia. Long-chain-long-chain-N-hydroxysulfosuccin-
imidobiotin (Sulfo-NHS-LC-LC-biotin) and 2-[4′-hydroxyazobenzene]-
benzoic acid (HABA) were purchased from Pierce. Porcine
carboxypeptidase B and yeast hexokinase were obtained from
Boehringer Mannheim. Recombinant H. influenzae tyrosyl-aminoacyl
tRNA synthetase was isolated from an over expressing E. coli strain as
a glutathione-S-transferase fusion and E. coli prolyl-aminoacyl tRNA
synthetase was isolated from an overexpressing E. coli strain. Agrobac-
terium faecalis β-glucosidase was a generous gift from Steve Withers
(University of British Columbia). Peptides were synthesized by
AnaSpec. The LOPAC library of compounds was purchased from
RBI/Sigma (Natick, MA).
Biotinylation of target proteins
Target proteins were biotinylated with sulfo-NHS-LC-LC-biotin to
achieve 2–5 moles of biotin per mole of target protein following the
manufacturer’s protocol. The extent of biotinylation was determined
using HABA according to the manufacturer’s instructions.
Affinity selection of phage-displayed peptides
Affinity selection of peptides was conducted essentially as described
[21]. The proteins were analyzed before affinity selection by SDS–
PAGE for purity and Km, kcat determinations for the relevant substrates
were also carried out to ensure that the catalytic activity of the targets
was in reasonable agreement with published values. For targets that
were biotinylated, activity assays were conducted before and after
biotinylation. Phage displaying peptides that bound to the targets were
selected using protein immobilized by the following methods.
Method 1. Target protein was immobilized directly on the plastic
surface of a 96-well plate. Target protein (0.5–1 µg/well) was incu-
bated in a 96-well plate overnight at 4°C in 0.1 M NaHCO3, pH 8. The
wells were blocked with 0.1% BSA in 0.1 M NaHCO3, pH 8 prior to
the addition of phage libraries. 
Method 2. The target protein was biotinylated and captured
on streptavidin-coated paramagnetic particles. Biotinylated-target
protein (0.5–1 µg) was bound to streptavidin paramagnetic particles.
Excess biotin-binding sites were blocked with biotin prior to adding
the phage libraries.
Method 3. Biotinylated-target protein and phage were incubated
together in solution prior to capturing the target-phage complex on
streptavidin-coated paramagnetic particles. Biotinylated target protein
(0.5–1 µg) was incubated in solution with the phage libraries for affinity
selection. The target–phage complex was then captured on strepta-
vidin paramagnetic particles.
Method 4. The target protein was biotinylated and captured on strep-
tavidin-coated 96-well plates. Excess biotin-binding sites were blocked
with biotin prior to the addition of the phage libraries.
After three or four rounds of selection, individual phage were tested for
binding to the target and several unrelated proteins. 
Phage libraries
Phage libraries were either PHD7 and PHD12 (New England
Biolabs) that display either 7- or 12-residue peptides, a random
12-mer library kindly supplied by Brian Kay (University of Wisconsin,
Madison), or random 11-residue peptides fused to gene III in which
the central residue of each library was fixed with a different residue.
Each library had a complexity between 5 × 108 and 2 × 109. The con-
struction and comparison of these libraries with random libraries will
be described elsewhere.
Phage ELISA assays
Following affinity selection, eluted phage were plated and individual
plaques were picked and amplified overnight in 2× YT. The isolates
were tested in phage ELISAs as described previously [21]. In brief,
targets were immobilized in microtiter wells, phage were added and
allowed to bind, the plates were washed and a horse radish peroxidase
(HRP)-linked antibody directed against the major coat protein of the
phage was used to detect phage bound to the target. HRP was
detected using 2,2′-azinobis(3-ethylbenzthazolinesulfonic acid) (ABTS)
a substrate and reading the absorbance at 405 nm. Phage producing a
strong signal at 405 nm that was dependent on the presence of the
target were plaque purified, amplified and tested for binding to target
protein and a series of unrelated proteins in a phage ELISA to verify
specificity of binding. 
Sequencing of phage-displayed peptides
Single-strand DNA was prepared using the Qiagen M13 single-strand
prep kit. Automated DNA sequencing was conducted by the Sequenc-
ing Facility at the University of North Carolina, Chapel Hill. 
Phage affinity titrations
The relative affinities of the selected phage were determined for each
target by conducting phage ELISAs using serial dilutions of phage on
a single target protein concentration. An 11-point, twofold dilution
series from 50 µl was used in the titrations. Background signals of
target protein exposed to antibody but no phage were subtracted from
each value. Phage titers were determined, and the absorbance read-
ings from the phage ELISAs were plotted as a function of plaque
forming units per assay. Absorbance readings at 405 nm produced by
1 × 109 pfu were all in a linear responsive range and these are pre-
sented in Table 2 to judge relative affinities of the displayed peptides.
Phage:peptide competition assays
Phage:peptide competitions were conducted by pre-incubating the
immobilized target protein with 100 µM synthetic peptide for 20 min.
Phage from a fresh overnight culture were added without a wash step
and the phage ELISA was conducted as described above. 
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Enzyme activity characterization
TyrRS. The activity of the TyrRS from H. influenzae was monitored by
charging tRNA with [3H]-tyrosine followed by trichloroacetic acid
(TCA) precipitation essentially as described previously [22].
Pro-RS. The activity of the Pro-RS from E. coli was monitored by
charging tRNA with [3H]-proline followed by TCA precipitation essen-
tially as described previously [22]. 
β-Glucosidase. Reactions were monitored by following the cleavage
of p-nitrophenyl-β-D-glucopyranoside by measuring the absorbance at
405 nm as previously described [23].
Hexokinase. Hexokinase activity was followed by using a coupled assay
with glucose 6-phosphate dehydrogenase and monitoring the reduction
of NADP+ at 340 nm as described in the manufacturer’s data sheet. 
Carboxypeptidase B. Carboxypeptidase B activity was assayed by
measuring the cleavage of Hippuryl–arginine or Furyl-acryloyl–alanine–
lysine at pH 7.5 in the presence of 100 mM NaCl [24].
Glycogen phosphorylase a. Enzymatic activity was monitored spec-
trophotometrically using a coupled enzyme assay with phosphoglycero-
mutase and glucose-6-phosphate dehydrogenase. Following hydrolysis
of glycogen by glycogen phosphorylase, the resulting glucose-1-phos-
phate was converted to glucose-6-phosphate by phosphoglyceromu-
tase. The resulting glucose-6-phosphate then serves as a substrate for
glucose-6-phosphate dehydrogenase along with NADP. The conver-
sion of NADP to NADPH is monitored at 340 nm resulting in an
increase in absorbance upon hydrolysis of glycogen. 
Alcohol dehydrogenase. Alcohol dehydrogenase activity was deter-
mined by monitoring the reduction of NAD+ at 340 nm.
Enzyme inhibition studies
Inhibition studies were performed using the synthetic peptides
described in the text. This was done by holding one substrate concen-
tration constant at 10× the Km concentration, while varying the concen-
trations of peptide, and varying the other substrate concentration
around Km. Initial velocity data were then fitted to the various inhibition
patterns using GraFit.
Peptide binding assay
Flash plate assay format. TyrRS, immobilized on Flashplates (New
England Nuclear), was preincubated in the presence of various con-
centrations of inhibitors before the addition of biotinylated Tyr-1 or
Tyr-4 peptides. The level of TyrRS–peptide interaction was monitored
by adding streptavidin labeled with 35S and allowing it to bind to the
TyrRS–peptide complex. The amount of 35S-streptavidin-biotin-
peptide–target complex in each well was determined by aspirating the
buffer, followed by scintillation counting.
Time-resolved fluorescence method. Polystyrene high protein
binding 384-well plates (Costar) were coated with 0.25 µg strepta-
vidin in 20 µl 0.1 M NaHCO3 per well and blocked with 1% BSA. The
plates were washed 3× with TBST (10 mM Tris–Cl, pH 8, 150 mM
NaCl, 0.05% Tween-20), 0.5 pmol TyrRS per well in 20 µl TBST was
added and allowed to bind, followed by three washes with TBST.
Compounds (20 µl in TBST) were added to each well and incubated
at room temperature for 30 min prior to addition of 2 pmol 4:1
peptide/streptavidin-europium conjugate in 5 µl TBST containing
50 mM biotin. The plate was incubated at room temperature for 1 h
and washed 3× with TBST. 30 µl europium enhancement solution
(Wallac) was added to each well and fluorescent readings were
obtained with a POLARstar fluorimeter (BMG Lab Technologies) using
a < 400 nm excitation filter and a 620 nm emission filter. The europium
labeled streptavidin-biotinylated peptide conjugate was prepared by
adding 4 pmol biotinylated peptide per pmol streptavidin. After incuba-
tion on ice for 30 min, the remaining biotin binding sites were blocked
with biotin prior to addition to the assay plate.
Fluorescence polarization method. To each well of a 384-well
polystyrene plate (low protein binding, Costar), 10 µl of each com-
pound in TBST was added to 5 µl of 200 nM TyrRS. After incubation at
room temperature for 30 min, 5 µl of 40 nM oregon-green-labeled
peptide was added to each well and the plate was placed on a rotating
mixer at room temperature for 1 h. Fluorescence polarization readings
were obtained with a POLARstar fluorimeter (BMG Lab Technologies)
using a 485 nm excitation filter and a 520 nm emission filter.
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